Table 2.
All-cause mortality cohort | CVD incidence cohort | |
---|---|---|
Characteristics | N (%) | N (%) |
N included | 477 | 381 |
Sex | ||
Male | 264 (55.3) | 218 (57.2) |
Age at start of RRT (years) | ||
0–<2 | 30 (6.3) | 29 (7.6) |
2–<6 | 50 (10.5) | 47 (12.3) |
6–<12 | 113 (23.7) | 90 (23.6) |
12–<18 | 284 (59.5) | 215 (56.4) |
PRD | ||
CAKUT | 229 (48.0) | 180 (48.6) |
GN | 80 (16.8) | 59 (15.5) |
Other | 168 (35.2) | 137 (36.0) |
Initial RRT modality | ||
HD | 220 (46.1) | 155 (40.7) |
PD | 207 (43.4) | 180 (47.2) |
Tx | 50 (10.5) | 46 (12.1) |
RRT modality during follow-up | ||
D + Tx+ | 371 (77.8) | 289 (75.9) |
Pre-Tx | 50 (10.5) | 46 (12.1) |
HD + Tx- | 30 (6.3) | 24 (6.3) |
PD + Tx- | 26 (5.5) | 22 (5.8) |
CVD cardiovascular disease, RRT renal replacement therapy, PRD primary renal disease, CAKUT congenital anomalies of kidney and urinary tract, GN glomerulonephritis, HD haemodialysis, PD peritoneal dialysis, Tx transplanted. PD + Tx started on PD and not transplanted during follow-up, HD + Tx started on HD and not transplanted during follow-up, pre-Tx pre-emptive transplant, D + Tx + started on dialysis (PD or HD) and received a transplant during follow-up